SCHEMBL1058728

SCHEMBL1058728

Cc1ccc(Nc2cc3nc[nH]c(=O)c3c(Nc3ccc(N4CCOCC4)cc3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.56
ZAP70 P43403 10/20 0.51
PIK3CD O00329 1/20 0.49
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
MAPT P10636 4/20 0.48
LMNA P02545 1/20 0.48
JAK2 O60674 3/20 0.47
MAPK1 P28482 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
IGF1R P08069 1/20 0.45
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1054424 0.95 SYK (0.58) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1059680 0.92 SRC (0.52) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1057871 0.87 SRC (0.54) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1060654 0.86 SYK (0.51) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1057452 0.84 ZAP70 (0.56) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1059213 0.84 SYK (0.51) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1047700 0.84 SYK (0.57) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1056489 0.83 ZAP70 (0.48) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1059224 0.83 ADORA3 (0.55) SYKZAP70PIK3CDPIK3CAPIK3CB
SCHEMBL1053460 0.83 ZAP70 (0.58) SYKZAP70PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354526-B2 Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors IRM LLC (BM) 2013-01-15 US claimed
US-20110003790-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 US claimed
US-8354526-B2 Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors IRM LLC (BM) 2013-01-15 US disclosed
US-8354526-B2 Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors IRM LLC (BM) 2013-01-15 US disclosed
US-8354526-B2 Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors IRM LLC (BM) 2013-01-15 US disclosed
US-20110003790-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 US disclosed
US-20110003790-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 US disclosed
US-20110003790-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 US disclosed
WO-2009099801-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS IRM LLC (BM) 2009-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003790-A1 PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS ZAP70, FLT3, LCK SYK 18/4885ZAP70 1/4885PIK3CD 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.